Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP897186.RAkKkyVb5F-lK3e5mvK2c73avxluQfK9HRwM5kPhmuZnk130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP897186.RAkKkyVb5F-lK3e5mvK2c73avxluQfK9HRwM5kPhmuZnk130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP897186.RAkKkyVb5F-lK3e5mvK2c73avxluQfK9HRwM5kPhmuZnk130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP897186.RAkKkyVb5F-lK3e5mvK2c73avxluQfK9HRwM5kPhmuZnk130_provenance.
- NP897186.RAkKkyVb5F-lK3e5mvK2c73avxluQfK9HRwM5kPhmuZnk130_assertion description "[Irinotecan should be used cautiously in dialysis patients with metastatic colorectal cancer and screening for UGT1A polymorphisms may help in identifying patients with lower SN-38 glucuronidation rates and greater susceptibility to irinotecan-induced toxicity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP897186.RAkKkyVb5F-lK3e5mvK2c73avxluQfK9HRwM5kPhmuZnk130_provenance.
- NP897186.RAkKkyVb5F-lK3e5mvK2c73avxluQfK9HRwM5kPhmuZnk130_assertion evidence source_evidence_literature NP897186.RAkKkyVb5F-lK3e5mvK2c73avxluQfK9HRwM5kPhmuZnk130_provenance.
- NP897186.RAkKkyVb5F-lK3e5mvK2c73avxluQfK9HRwM5kPhmuZnk130_assertion SIO_000772 21617725 NP897186.RAkKkyVb5F-lK3e5mvK2c73avxluQfK9HRwM5kPhmuZnk130_provenance.
- NP897186.RAkKkyVb5F-lK3e5mvK2c73avxluQfK9HRwM5kPhmuZnk130_assertion wasDerivedFrom befree-2016 NP897186.RAkKkyVb5F-lK3e5mvK2c73avxluQfK9HRwM5kPhmuZnk130_provenance.
- NP897186.RAkKkyVb5F-lK3e5mvK2c73avxluQfK9HRwM5kPhmuZnk130_assertion wasGeneratedBy ECO_0000203 NP897186.RAkKkyVb5F-lK3e5mvK2c73avxluQfK9HRwM5kPhmuZnk130_provenance.
- befree-2016 importedOn "2016-02-19" NP897186.RAkKkyVb5F-lK3e5mvK2c73avxluQfK9HRwM5kPhmuZnk130_provenance.